Why Mounjaro Became South Africa's Biggest Medicine
By November 2025 it had eclipsed every other pharmaceutical sold in South Africa. The story of how a single weekly injection rewrote the local prescription market in twelve months.
Inside The SURPASS Trials
The clinical programme that established tirzepatide for type 2 diabetes. What each of the six trials measured, who they enrolled, and what the numbers actually showed.
Inside The SURMOUNT Trials
The weight management trial programme that produced 20 percent mean weight reduction and the SAHPRA October 2025 indication. A close reading of the five trials.
The Aspen Eli Lilly Partnership
The 2023 deal that made Aspen Pharmacare Mounjaro's South African distributor, the manufacturing implications, and what the SA-based partnership has meant for access in sub-Saharan Africa.
When Will Tirzepatide Generics Reach South Africa?
Generic semaglutide is coming. Tirzepatide is a much longer wait. The SA patent picture, when generics could arrive, and what it would mean for pricing.
Mounjaro After Fifty
The considerations that change as patients age. Kidney function, polypharmacy, bone health, lean mass, and the specific decisions that matter for older adults.
The Real World Data, So Far
Trials tell you what a medication can do in controlled conditions. Real world use tells you what it does in practice. The SA experience with tirzepatide, eighteen months in.